Literature DB >> 2050123

Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene.

J F Savouret1, A Bailly, M Misrahi, C Rauch, G Redeuilh, A Chauchereau, E Milgrom.   

Abstract

The transcription of the progesterone receptor gene is induced by estrogens and decreased by progestins. Studies were performed to define the regions of the gene and the molecular mechanisms involved. No hormonal regulation could be observed using 5' flanking regions of the gene up to -2762 in front of a heterologous gene. Estrogen and progestin regulation could be observed only when using fragments of the gene extending down to +788. Progressive deletions from the 5' and 3' ends, site-directed mutagenesis and DNase protection experiments with purified estrogen receptor suggested that the biologically active estrogen responsive element (ERE) is present at +698/+723, overlapping the initiation of translation. An oligonucleotide was synthesized bearing this ERE and shown to impart estrogen inducibility to a heterologous gene. Its regulation by anti-estrogens corresponded to that of the in situ progesterone receptor gene since tamoxifen was a partial agonist whereas ICI 164384 was a full antagonist. This ERE also mediated down-regulation by progestins in the presence of the progesterone receptor, even though it has no progesterone receptor binding ability. DNase footprinting showed that this effect was not due to a decrease of estrogen receptor affinity for the ERE in the presence of progesterone receptor. Finally, use of deletion mutants of the progesterone receptor showed that the steroid binding and the DNA binding domains were necessary for down-regulation whereas deletions of various parts of the N-terminal domain were without effect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050123      PMCID: PMC452862          DOI: 10.1002/j.1460-2075.1991.tb07713.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  66 in total

1.  Origin of the high constitutive level of progesterone receptor in T47-D breast cancer cells.

Authors:  J F Savouret; F Fridlanski; M Atger; M Misrahi; R Berger; E Milgrom
Journal:  Mol Cell Endocrinol       Date:  1991-02       Impact factor: 4.102

2.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A.

Authors:  S Green; P Walter; V Kumar; A Krust; J M Bornert; P Argos; P Chambon
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

3.  Sequence and expression of human estrogen receptor complementary DNA.

Authors:  G L Greene; P Gilna; M Waterfield; A Baker; Y Hort; J Shine
Journal:  Science       Date:  1986-03-07       Impact factor: 47.728

Review 4.  Steroid receptor regulated transcription of specific genes and gene networks.

Authors:  K R Yamamoto
Journal:  Annu Rev Genet       Date:  1985       Impact factor: 16.830

5.  Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells.

Authors:  J F Prud'homme; F Fridlansky; M Le Cunff; M Atger; C Mercier-Bodart; M F Pichon; E Milgrom
Journal:  DNA       Date:  1985-02

6.  One-step immunoaffinity purification of active progesterone receptor. Further evidence in favor of the existence of a single steroid binding subunit.

Authors:  F Logeat; R Pamphile; H Loosfelt; A Jolivet; A Fournier; E Milgrom
Journal:  Biochemistry       Date:  1985-02-12       Impact factor: 3.162

7.  The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor.

Authors:  D D Moore; A R Marks; D I Buckley; G Kapler; F Payvar; H M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription.

Authors:  J Drouin; M A Trifiro; R K Plante; M Nemer; P Eriksson; O Wrange
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

9.  The human estrogen receptor has two independent nonacidic transcriptional activation functions.

Authors:  L Tora; J White; C Brou; D Tasset; N Webster; E Scheer; P Chambon
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

10.  Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.

Authors:  R Schüle; P Rangarajan; S Kliewer; L J Ransone; J Bolado; N Yang; I M Verma; R M Evans
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

View more
  38 in total

Review 1.  A specific role for cyclin D1 in mammary gland development.

Authors:  P Sicinski; R A Weinberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 2.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

3.  Cutting SRC-1 down to size in endometriosis.

Authors:  Matthew T Dyson; Serdar E Bulun
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 4.  The future of antihormone therapy: innovations based on an established principle.

Authors:  K Parczyk; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  Role of estrogen receptor-β in endometriosis.

Authors:  Serdar E Bulun; Diana Monsavais; Mary Ellen Pavone; Matthew Dyson; Qing Xue; Erkut Attar; Hideki Tokunaga; Emily J Su
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

Review 6.  Mechanisms and significance of nuclear receptor auto- and cross-regulation.

Authors:  Pia Bagamasbad; Robert J Denver
Journal:  Gen Comp Endocrinol       Date:  2010-03-23       Impact factor: 2.822

Review 7.  Progestin receptor subtypes in the brain: the known and the unknown.

Authors:  Shaila Mani
Journal:  Endocrinology       Date:  2008-02-28       Impact factor: 4.736

8.  Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.

Authors:  A Rodriguez-Gonzalez; K Cyrus; M Salcius; K Kim; C M Crews; R J Deshaies; K M Sakamoto
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

9.  Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms.

Authors:  J J Watters; D M Dorsa
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

10.  Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.

Authors:  Frances Collins; Sheila MacPherson; Pamela Brown; Vincent Bombail; Alistair R W Williams; Richard A Anderson; Henry N Jabbour; Philippa T K Saunders
Journal:  BMC Cancer       Date:  2009-09-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.